Both of these points are likely to be of relevance to the management of patients with AF. Patients with heart failure, irrespective of ejection fraction, frequently have AF. Disentangling whether a ...

Inflammatory arthritis encompasses a group of autoimmune diseases, including rheumatoid arthritis (RA), psoriatic arthritis ...

In the new analysis of data from the SUMMIT trial, researchers focused on patients with obesity, chronic kidney disease and heart failure with preserved ejection fraction because they commonly have ...

Human Heat Tolerance Lower Than Previously Believed: Study FindsA study from the University of Ottawa’s Human and ...

Findings presented at the American College of Cardiology Annual Scientific Session indicate that finerenone's efficacy in ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

Severity of cardiometabolic comorbidity burden affects risk for all-cause hospitalization in patients with heart failure.

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

A team of scientists led by Northwestern Medicine investigators have uncovered new details about a deadly heart condition ...

A gene therapy for heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure, has shown ...